Here are four things to know:
- PBMs, the middlemen managing most U.S prescriptions, have faced scrutiny for allegedly inflating drug prices and reducing reimbursements for smaller pharmacies.
- This year, some Georgia pharmacists hoped state lawmakers would pass legislation that would level the playing field by increasing reimbursements for independent pharmacies. However, Gov. Brian Kemp vetoed the bill, citing a projected $45 million annual cost to the state, the report said.
- The disparities can be stark, with one Georgia pharmacy receiving $5.54 for a prescription of antidepressant bupropion while nearby chain pharmacies received almost $54 for the same drug.
- The Federal Trade Commission is suing major PBMs for anti-competitive practices, accusing them of driving up drug costs. Despite these efforts, many small pharmacies are closing, with nearly one independent pharmacy shutting down daily across the U.S., according to KFF Health News.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.